Interview with Dr. Paul Stoffels, Johnson & Johnson
Listen now
Description
Listen in as Dr. Maria Freire explores the work of Dr. Paul Stoffels, Johnson & Johnson’s Vice Chairman of the Executive Committee and Chief Scientific Officer, and his team as they have worked since April 2020 developing COVID-19 vaccines and monitoring emerging variants. Along with Dr. Francis Collins, Director of NIH, Dr. Stoffels co-chairs  Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), the historic public-private partnership created to combat COVID-19 on all fronts.
More Episodes
In this episode, Dr. Maria Freire sits down with Dr. Anne Schuchat, Principal Deputy Director of the Centers for Disease Control and Prevention. Learn how the CDC evaluates data when issuing guidance to the public, as well as its role in surveillance of new COVID-19 variants. According to Dr....
Published 06/03/21
What is ACTIV and why is it so important to the public? Listen as Dr. Maria Freire, President and Executive Director of the FNIH sits down with David Wholley, the FNIH's Senior Vice President of Research Partnerships, to tell the story of how the Accelerating COVID-19 Therapeutic Interventions...
Published 05/06/21